Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is based in Dallas, Texas.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-05-08 |
2024-03 |
0.05 |
0.07 |
0.02 |
40.00% |
2024-03-06 |
2023-12 |
0.02 |
0.06 |
0.04 |
200.00% |
2024-03-06 |
2023-12 |
0.02 |
N/A |
N/A |
N/A |
2023-11-07 |
2023-09 |
0.04 |
0.03 |
-0.01 |
-25.00% |
2023-11-07 |
2023-09 |
0.04 |
N/A |
N/A |
N/A |
2023-08-09 |
2023-06 |
0.14 |
N/A |
N/A |
N/A |
Date |
Firm |
Action |
From |
To |
2023-08-10 |
Credit Suisse |
Upgrade |
Neutral |
Neutral |
2023-07-16 |
Goldman Sachs |
Upgrade |
Neutral |
Neutral |
2023-03-15 |
Goldman Sachs |
Upgrade |
|
Neutral |
2023-02-16 |
Citigroup |
Upgrade |
|
Neutral |
2023-02-15 |
Credit Suisse |
Upgrade |
|
Neutral |
2022-12-12 |
CJS Securities |
Upgrade |
|
Market Perform |
Date |
Name |
Relation |
Quantity |
Description |
2024-02-29 |
BLACK DYLAN C |
General Counsel |
25.47K |
Stock Award(Grant) |
2024-05-16 |
BOLTON JEFFREY |
Director |
52.30K |
Purchase |
2024-02-29 |
CARLISLE CRISSY BUCHANAN |
Chief Financial Officer |
88.34K |
Stock Award(Grant) |
2024-05-13 |
HOEFLINGER ERIN P |
Director |
30.40K |
Purchase |
2024-02-29 |
JACOBSMEYER BARBARA ANN |
Chief Executive Officer |
470.99K |
Stock Award(Grant) |
2024-02-29 |
JOLLEY JULIE DIANE |
Officer |
71.43K |
Stock Award(Grant) |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Blackrock Inc. |
8.16M |
93.85M |
16.29% |
2023-06-29 |
Vanguard Group Inc |
5.77M |
66.35M |
11.51% |
2023-06-29 |
Deerfield Management Company, L.P. (Series C) |
4.81M |
55.31M |
9.60% |
2023-06-29 |
Jana Partners LLC |
2.47M |
28.46M |
4.94% |
2023-06-29 |
Arex Capital Management, Lp |
2.29M |
26.29M |
4.56% |
2023-06-29 |
Cruiser Capital Advisors, Llc |
2.06M |
23.68M |
4.11% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-09-29 |
iShares Core S&P Smallcap ETF |
3.38M |
38.07M |
6.75% |
2023-06-29 |
Janus Henderson Small Cap Value Fund |
1.65M |
18.99M |
3.30% |
2023-06-29 |
Vanguard Total Stock Market Index Fund |
1.54M |
17.73M |
3.08% |
2023-06-29 |
Vanguard Small-Cap Index Fund |
1.29M |
14.87M |
2.58% |
2023-08-30 |
iShares Russell 2000 ETF |
1.15M |
14.70M |
2.29% |
2023-06-29 |
Vanguard Small Cap Value Index Fund |
895.70K |
10.30M |
1.79% |